Dergiler / Turkish Journal of Medical Sciences / 2017 / Cilt: 47 - Sayı: 3

Evaluation of polyneuropathy and associated risk factors in children with type 1 diabetes mellitus

Sayfa
942–946
Yayın Tarihi
2022-11-05
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Planning prospective studies with long-term evaluations on nerve conduction in children with DM will be beneficial for this subject.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Background/aim: Diabetes mellitus (DM) is one of the most common metabolic diseases seen in the world today.
📊
Temel Bulgular & Veri:Our main objective in this study is to determine the incidence rate of DN in pediatric DM patients and assess the risk factors associated with DN.
💡
Sonuç & Katkı:Planning prospective studies with long-term evaluations on nerve conduction in children with DM will be beneficial for this subject.
🔬Tür:Literatür & Derleme Çalışması
📍Kapsam:2011 Verileri
⚙️Değişkenler:Alan Parametreleri

Abstract

Background/aim: Diabetes mellitus (DM) is one of the most common metabolic diseases seen in the world today. Diabetic neuropathy (DN) is a chronic complication of the disease that is rarely reported in children, since it has a relatively longer latency period. Our main objective in this study is to determine the incidence rate of DN in pediatric DM patients and assess the risk factors associated with DN. Materials and methods: Data from 111 patients from January 2011 to May 2014 were reviewed in a retrospective manner. Nerve conduction studies were performed as the gold standard in diagnosis. Results: The incidence rate of symptomatic DN was 13.5% according to our study results. The EMG-diagnosed DN incidence rate was calculated as 22.5%. Following linear regression analysis, positive correlation was found between diabetes duration, diabetic ketoacidosis, and DN presence. Conclusion: Our study results demonstrate the fact that poor metabolic control, especially during early stages of the disease, is a major risk factor for neuropathy development. Planning prospective studies with long-term evaluations on nerve conduction in children with DM will be beneficial for this subject.

🔖

Bu Makaleye Atıf Yap

ÜNALP, A., EDİZER, S., GÜZEL, O., TÜRKYILMAZ, H. (2022). Evaluation of polyneuropathy and associated risk factors in children with type 1 diabetes mellitus. Turkish Journal of Medical Sciences, Cilt: 47 - Sayı: 3, 942–946. https://ajindex.com/articles/610443

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (12)

  1. Vinik AI. Diabetic neuropathy: pathogenesis and therapy. Am J Med 1999; 107: 17-26
  2. Young MJ, Boulton AJ, MacLeod AF, Williams DR, Sonksen PH. A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia 1993; 36: 150-154
  3. Dyck PJ, Thomas PK. Peripheral Neuropathy. 3rd ed. Philadelphia, PA, USA: W.B. Saunders Company; 1993
  4. Höliner I, Haslinger V, Lütschg J, Müller G, Barbarini DS, Fussenegger J, Zanier U, Saely CH, Drexel H, Simma B. Validity of the neurological examination in diagnosing diabetic peripheral neuropathy. Pediatr Neurol 2013; 49: 171-177
  5. Tesfaye S, Chaturvedi N, Eaton SE, Ward JD, Manes C, IonescuTirgoviste C, Witte DR, Fuller JH; EURODIAB Prospective Complications Study Group. Vascular risk factors and diabetic neuropathy. N Engl J Med 2005; 352: 341-350
  6. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulindependent diabetes mellitus. N Engl J Med 1993; 329: 977-986
  7. Hanssen KF. Blood glucose control and microvascular and macrovascular complications in diabetes. Diabetes 1997; 46: 101-103
  8. Gökşen Şimşek D, Aycan Z, Özen S, Çetinkaya S, Kara C, Abalı S, Demir K, Tunç Ö, Uçaktürk A, Asar G et al. Diabetes care, glycemic control, complications, and concomitant autoimmune diseases in children with type 1 diabetes in Turkey: a multicenter study. J Clin Res Pediatr Endocrinol 2013; 5: 20-26
  9. Dyck PJ, Davies JL, Wilson DM, Service FJ, Melton LJ 3rd, O’Brien PC. Risk factors for severity of diabetic polyneuropathy: intensive longitudinal assessment of the Rochester Diabetic Neuropathy Study cohort. Diabetes Care 1999; 22: 1479-1486
  10. Hyllienmark L, Alstrand N, Jonsson B, Ludvigsson J, Cooray G, Wahlberg-Topp J. Early electrophysiological abnormalities and clinical neuropathy: a prospective study in patients with type 1 diabetes. Diabetes Care 2013; 36: 3187-3194
  11. Charles M, Soedamah-Muthu SS, Tesfaye S, Fuller JH, Arezzo JC, Chaturvedi N, Witte DR; EURODIAB Prospective Complications Study Investigators. Low peripheral nerve conduction velocities and amplitudes are strongly related to diabetic microvascular complications in type 1 diabetes: the EURODIAB Prospective Complications Study. Diabetes Care 2010; 33: 2648-2653
  12. Marcus J, Ehrlich R, Kelly M, Murphy EG. Nerve conduction in childhood diabetes. Can Med Assoc